Travel & financial grants

HAE International

This travel grant assists people with HAE and their close relatives (caregivers) living in North, Central, or South America to attend the 2026 HAEi Regional Conference Americas in Ottawa, Canada. The application website is currently open. While it specifies a 'Travel Grant', the types of expenses covered are not detailed.

AbbVie Patient Assistance Foundation

The AbbVie Patient Assistance Foundation provides various AbbVie prescription medications, such as Androgel, Creon, Humira, Lupron Depot, and others, at no cost. It is designed for patients experiencing financial difficulties who may or may not have prescription medication benefits through private insurance or government programs.

Bristol Myers Squibb

This program, offered by Bristol Myers Squibb, provides patient access, reimbursement, and co-pay assistance for ABRAXANE medication to eligible commercially insured patients. No information regarding travel assistance, such as coverage for flights, hotel, or gas, is provided on this page.

Bristol Myers Squibb

This page describes the BMS Access Support program, which provides resources for patients to understand insurance coverage and find financial support, including co-pay assistance for ABRAXANE medication. It does not offer a patient travel assistance grant.

Bristol Myers Squibb

This page describes the BMS Access Support® program, which helps patients understand their insurance coverage and find financial support, including co-pay assistance for ABRAXANE for eligible commercially insured patients. This program does not appear to offer travel assistance grants.

Bayer

Access Services by Bayer is a free support program offered by Bayer for patients on Stivarga therapy. It provides information about the therapy and available financial assistance options, but does not directly offer grants or cover specific expenses like travel. Eligibility for the support program or the financial options it refers to is not detailed.

Accessia Health

The Accessia Health Kidney Stones Financial Assistance program offers financial support for US and Puerto Rico residents with public insurance (Medicare/Medicaid) needing medications for kidney stones, such as Cystadane. The needs-based program covers copayments, premiums, ancillary services, infusion and nursing services, and travel, with an annual maximum benefit of $5000.

Accessia Health

The Accessia Health: Gaucher Disease - Private Insurance program provides financial assistance for US and Puerto Rico residents diagnosed with Gaucher Disease. It covers various expenses including copayment, premium, ancillary services, infusion, nursing, and travel, with an annual maximum benefit of $10,000. Eligibility is needs-based, requiring income documentation and commercial insurance, underinsurance, or no insurance.

Accessia Health

This financial assistance program, named Accessia Health: Hereditary Angioedema - Public Insurance, is currently listed as 'Not Funded'. Therefore, it is not accepting applications, and details regarding its coverage or specific eligibility criteria are not available.

Accessia Health

The Accessia Health: Hereditary Angioedema - Public Insurance program offers up to $7500 annually in financial assistance, covering copay, premium, ancillary, infusion, nursing, and travel costs. It is for US and Puerto Rico residents with Hereditary Angioedema who have public insurance (Medicare/Medicaid) and demonstrate financial need, requiring income documentation.

Accessia Health

The Accessia Health: Hereditary Angioedema - Public Insurance program provides financial assistance for medications, copayments, premiums, and ancillary services, including travel. It is for US or Puerto Rico residents with hereditary angioedema, specific insurance (Medicare/Medicaid), and demonstrated financial need.

Accessia Health

The Accessia Health: Hereditary Angioedema - Public Insurance program provides up to $7500 annually for US residents with public insurance to cover various costs, including copayment, premium, ancillary services, infusion, nursing services, and travel. Patients must have a diagnosis of Hereditary Angioedema and submit income documentation, along with other personal and insurance details, to qualify.

Accessia Health

The Accessia Health: Hereditary Angioedema - Public Insurance program provides financial assistance, including travel, copay, premium, ancillary, infusion, and nursing services, with a $7500 annual maximum benefit. It is available to qualified individuals residing in the US or a US Territory with hereditary angioedema who are enrolled in Medicare/Medicaid and demonstrate financial need.

Accessia Health

The Accessia Health: MPS-1 program provides vital financial support for patients using Aldurazyme, covering medical expenses such as copayments, premiums, and travel. It is a needs-based program for residents of the US and Puerto Rico, requiring applicants to submit diagnosis, income, and insurance details to apply online or by phone.

Accessia Health

The Accessia Health Thrombotic Thrombocytopenic Purpura (TTP) program offers up to $5500 annually for US and Puerto Rico residents needing Cablivi and Adzynma. It covers medical expenses including copayments, premiums, ancillary services, infusion, nursing, and travel assistance. Eligibility is needs-based and requires patients to be enrolled in Medicare/Medicaid, provide income documentation, and a Medical Care Provider Statement.

Mallinckrodt

The Acthar Support & Access Program (A.S.A.P.), offered by Mallinckrodt, provides a $0 co-pay for Acthar prescriptions to eligible patients. To qualify, individuals must be 18 or older, have commercial or private insurance, and not be covered by Medicare, Medicaid, or other federal or state health care programs. A.S.A.P. also offers patient support services including home injection training and access to a 24-hour nurse helpline.

PAN Foundation

The PAN Foundation provides financial assistance, including coverage for transportation purchases, for patients with Acute Myeloid Leukemia. To qualify, applicants must meet an income requirement of up to 500% of the Federal Poverty Level. The maximum grant amount available for this assistance is $4400.

Novartis

This grant is a copay assistance program for patients prescribed Afinitor (everolimus) for cancer or tuberous sclerosis complex (TSC) treatment. It helps commercially insured patients access manufacturer copay cards and coordinates patient assistance programs for Medicare, Medicaid, and uninsured patients through foundations like the Novartis Patient Assistance Foundation. The program aims to reduce or eliminate out-of-pocket medication costs, with QuickRx providing free support services including enrollment, insurance coordination, and home delivery.

Novartis Pharmaceuticals

This program, facilitated by QuickRx, offers copay assistance for the medication Afinitor (everolimus) to reduce out-of-pocket costs for eligible patients. It coordinates access to manufacturer copay cards for commercially insured patients and patient assistance programs, including foundation grants, for Medicare, Medicaid, and uninsured patients, aiming for $0 patient cost.

Genentech

ALECENSA Access Solutions helps patients understand their insurance coverage and provides financial assistance options to obtain their prescribed Genentech medicine. The page content, however, does not indicate this program offers travel assistance or covers travel-related expenses.

Alex's Lemonade Stand Foundation

The Alex's Lemonade Stand Foundation Travel Fund covers various travel expenses including airline tickets, gas cards, rail tickets, and cab/parking vouchers, as well as lodging and meal vouchers. It is available to patients under 21 and in active cancer treatment. Applications must be initiated by a certified healthcare professional, and families must be receiving treatment at a partner facility.

Alex's Lemonade Stand

The Alex's Lemonade Stand Travel For Care Program covers airline tickets, gas cards, rail tickets, cab, or parking vouchers for travel, as well as hotels, philanthropic housing, and food vouchers for meals. Eligible patients must be under 21 and in active cancer treatment, with applications initiated by a certified healthcare professional. Families must be receiving cancer treatment at a partner facility.

Alnylam Pharmaceuticals

Alnylam Assist provides patient support services, initiated by completing a Start Form with a doctor. An Alnylam Case Manager will contact the patient and doctor to share an insurance benefits summary and initiate support. The page does not explicitly detail coverage for travel expenses.

American Cancer Society

The American Cancer Society Road to Recovery program provides rides to and from cancer treatment appointments. It is for cancer patients who do not have a ride or are unable to drive themselves and are traveling to a cancer-related medical appointment.

Amgen

Amgen

The Amgen SupportPlus program offers personalized patient support for individuals prescribed Amgen medications, including Vectibix. However, the provided page content does not explicitly detail what types of travel expenses are covered, nor does it specify eligibility criteria, income requirements, or the application process for the Vectibix Cost Assistance grant.

Amgen

The Assistance Fund for Neuromyelitis Optica Spectrum Disorder (NMOSD) offers financial support for FDA-approved treatments, including Uplizna, covering out-of-pocket costs, insurance premiums, and medical expenses. It is open to US and Puerto Rico residents with commercial insurance, Medicare, or Medicaid, and eligibility is based on financial need, requiring annual re-enrollment.

Amgen Inc.

This program, Amgen SupportPlus Vectibix, offers financial assistance and resources for patients to access Vectibix, regardless of their insurance type (commercial, government, or uninsured). It primarily focuses on support for medication costs and does not appear to cover travel expenses.

Amgen

The Assistance Fund

The Amyloidosis Financial Assistance Program, run by The Assistance Fund, provides financial assistance for out-of-pocket costs related to Amyloidosis treatment, including prescription drug costs, health insurance premiums, therapy administration, genetic testing, and travel expenses (ground transportation, air travel, meals, hotel stays) to treatment centers or physicians. Eligibility requires being a U.S. citizen or permanent resident, diagnosed with Amyloidosis, prescribed an FDA-approved treatment, having prescription coverage, and meeting financial eligibility based on household income and size. The program is currently on a waitlist.

PAN Foundation

The PAN Foundation offers financial assistance, including grants that can cover transportation purchases for patients. While the named grant is for amyloidosis medication copay, transportation assistance is generally listed as a covered item under PAN grants. Eligibility requires applicants to verify their income, though a specific FPL cap is not provided.

The Assistance Fund

The Amyotrophic Lateral Sclerosis Financial Assistance Program provides financial aid for US citizens or permanent residents diagnosed with ALS who are prescribed an FDA-approved treatment with prescription coverage and meet financial eligibility criteria. It covers out-of-pocket expenses including prescription copays, health insurance premiums, therapy administration, and travel costs (ground/air transportation, meals, hotel stays) for treatment or physician visits. The program is currently accepting requests to join its enrollment waitlist.

The Assistance Fund

The Assistance Fund: Duchenne Muscular Dystrophy provides financial support for U.S. and Puerto Rico residents to cover copays, coinsurance, deductibles, health insurance premiums, and incidental medical expenses for FDA-approved Duchenne Muscular Dystrophy treatments. Eligibility is needs-based and requires patients to be commercially insured, Medicare, or Medicaid recipients.

The Assistance Fund

The Assistance Fund: Idiopathic Hypersomnia (IH) program offers financial assistance for out-of-pocket expenses related to FDA-approved treatments for idiopathic hypersomnia, including copays, coinsurance, deductibles, and health insurance premiums. It is available to commercially insured or Medicare/Medicaid patients residing in the US and Puerto Rico who meet needs-based criteria.